|Articles|October 1, 2018
- Pharmaceutical Executive-10-01-2018
- Volume 38
- Issue 10
Pharmaceutical Executive, October 2018 Issue (PDF)
Click the title above to open the Pharmaceutical October 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Pharm Exec's Emerging Pharma Leaders 2018almost 8 years ago
Choosing the Right Track: Pharma & Healthcare MBAsalmost 8 years ago
Getting Where You Need to Goalmost 8 years ago
Vienna’s Vision on Health Regulation in Europealmost 8 years ago
FDA Launches Major Push for New Antimicrobialsalmost 8 years ago
Medical Affairs’ Search for MeaningAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
5